In situ conversion of defective Treg into SuperTreg cells to treat advanced IPEX-like disorders in mice
Open Access
- 3 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 11 (1), 1-12
- https://doi.org/10.1038/s41467-020-15836-2
Abstract
Mutations disrupting regulatory T (Treg) cell function can cause IPEX and IPEX-related disorders, but whether established disease can be reversed by correcting these mutations is unclear. Treg-specific deletion of the chromatin remodeling factor Brg1 impairs Treg cell activation and causes fatal autoimmunity in mice. Here, we show with a reversible knockout model that re-expression of Brg1, in conjunction with the severe endogenous proinflammatory environment, can convert defective Treg cells into powerful, super-activated Treg cells (SuperTreg cells) that can resolve advanced autoimmunity, with Brg1 re-expression in a minor fraction of Treg cells sufficient for the resolution in some cases. SuperTreg cells have enhanced trafficking and regulatory capabilities, but become deactivated as the inflammation subsides, thus avoiding excessive immune suppression. We propose a simple, robust yet safe gene-editing-based therapy for IPEX and IPEX-related disorders that exploits the defective Treg cells and the inflammatory environment pre-existing in the patients.Keywords
This publication has 42 references indexed in Scilit:
- Functional reprogramming of regulatory T cells in the absence of Foxp3Nature Immunology, 2019
- A major chromatin regulator determines resistance of tumor cells to T cell-mediated killingScience, 2018
- From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulationAnnals of the New York Academy of Sciences, 2016
- Exclusive Transduction of Human CD4+ T Cells upon Systemic Delivery of CD4-Targeted Lentiviral VectorsPublished by The American Association of Immunologists ,2015
- CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsetsThe Journal of Experimental Medicine, 2013
- MASTR: A Technique for Mosaic Mutant Analysis with Spatial and Temporal Control of Recombination Using Conditional Floxed Alleles in MiceCell Reports, 2012
- The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cellsNature Immunology, 2011
- In Vitro Treg Suppression AssaysPublished by Springer Science and Business Media LLC ,2011
- X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfyNature Genetics, 2001
- The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3Nature Genetics, 2001